CIVALLERO, Monica
 Distribuzione geografica
Continente #
NA - Nord America 2.416
EU - Europa 961
AS - Asia 324
SA - Sud America 7
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.715
Nazione #
US - Stati Uniti d'America 2.410
GB - Regno Unito 352
IT - Italia 183
SE - Svezia 145
CN - Cina 114
DE - Germania 79
HK - Hong Kong 67
SG - Singapore 51
UA - Ucraina 43
TR - Turchia 42
FR - Francia 36
FI - Finlandia 29
IE - Irlanda 27
BG - Bulgaria 23
BE - Belgio 13
IN - India 13
ID - Indonesia 9
JP - Giappone 7
VN - Vietnam 7
CA - Canada 6
MY - Malesia 6
LT - Lituania 5
RU - Federazione Russa 5
CH - Svizzera 4
CL - Cile 4
NL - Olanda 4
A2 - ???statistics.table.value.countryCode.A2??? 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
IR - Iran 2
PE - Perù 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BR - Brasile 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 3.715
Città #
Fairfield 375
Southend 304
Chandler 259
Woodbridge 236
Ashburn 232
Houston 155
Ann Arbor 130
Seattle 119
Cambridge 117
Nyköping 109
Wilmington 104
Jacksonville 82
Dearborn 78
Hong Kong 66
Modena 53
Beijing 38
San Diego 38
New York 37
Singapore 31
Dublin 27
Izmir 27
Princeton 25
Sofia 23
Fremont 22
Eugene 19
Frankfurt am Main 16
Helsinki 15
London 15
Brussels 13
Cologno Monzese 13
Milan 13
Norwalk 12
Des Moines 10
Jakarta 9
San Giuliano Milanese 9
Bremen 8
Falls Church 8
Brusaporto 7
Chicago 7
Dong Ket 6
Redwood City 6
Boardman 5
Latina 5
Parma 5
Nanjing 4
Ottawa 4
Rome 4
Shanghai 4
Ascoli Piceno 3
Atlanta 3
Chongqing 3
Grafing 3
Hefei 3
Kuala Lumpur 3
Kunming 3
Munich 3
Naples 3
Phoenix 3
Reggio Emilia 3
Tappahannock 3
Auburn Hills 2
Augusta 2
Belgrade 2
Bereguardo 2
Bologna 2
Brno 2
Changsha 2
Clearwater 2
Desio 2
Edinburgh 2
Fisciano 2
Genoa 2
Guangzhou 2
Indiana 2
Lappeenranta 2
Las Vegas 2
Leawood 2
Lima 2
Los Angeles 2
Mansfield 2
Melzo 2
Mondolfo 2
Prescot 2
Quinto di Treviso 2
Rende 2
Saint Louis 2
Sant'Ilario d'Enza 2
Washington 2
Wuhan 2
Zurich 2
Almaty 1
Almere Stad 1
Amsterdam 1
Arceto 1
Ardabil 1
Auckland 1
Bangalore 1
Baotou 1
Berlin 1
Brindisi 1
Totale 3.010
Nome #
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 266
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 233
Activity of BKM120 and BEZ235 against lymphoma cells 231
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 219
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 207
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 196
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 190
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 180
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 178
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 177
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 174
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 173
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 172
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 149
Molecular targeting of the PKC-β inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression 138
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 137
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 108
Survival outcomes for extranodal natural-killer T-cell lymphoma – Authors' reply 101
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project 98
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project 87
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas 79
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project 75
COVID-related disruption in mammographic screening: a year later. 55
Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy 53
The Value and relevance of T-cell lymphoma registries 53
The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network 22
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project 10
Totale 3.761
Categoria #
all - tutte 15.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020631 0 22 16 39 57 109 125 76 81 42 39 25
2020/2021742 72 99 46 71 87 45 40 79 31 83 51 38
2021/2022555 36 29 63 29 9 64 36 22 44 46 107 70
2022/2023648 74 114 44 66 43 95 7 57 88 7 25 28
2023/2024421 18 24 18 50 82 34 43 47 5 17 48 35
2024/202558 50 8 0 0 0 0 0 0 0 0 0 0
Totale 3.761